IL2 and osteoporosis: On the contrary, Aschroft et al. showed the opposite in bone alterations in a mouse model of colitis (IL-2-deficient mice) after an exogenous administration of OPG, therefore suggesting that OPG is protective against osteoporosis and its possible role as a therapeutic agent [30].